Alzheimer’s Disease

Impact of Alzheimer’s disease treatments on apathy

Modifiable dementia risk factors associated with higher CSF tau and poorer cognition in middle age

The prodromal phases of Alzheimer’s disease

Improving diet to reduce risk of cogntive decline and dementia

Role of ancestry in the predictivity of genetic data

Early predictive value of plasma biomarkers for amyloid positivity

CSF tau as a biomarker of therapeutic effect

Potential benefits of an anti-Aβ vaccine over monoclonal antibodies

Tackling diet and lifestyle for dementia prevention: new findings

Fluid biomarkers of immune function in Alzheimer’s disease

Deep molecular profiling to identify new genetic variants and drug targets in Alzheimer’s disease

Optimized anti-Aβ vaccination enters clinical trials in Alzheimer’s disease

Combining genetics and molecular biomarkers for Alzheimer’s disease prognostication

Apathy in dementia

Reactive astrocytes as therapeutic targets in neurodegenerative disease

Impact of race and ethnicity on greenspace-brain health associations